Quantitative Models in Life Science Business : From Value Creation to Business Processes.
Main Author: | |
---|---|
Other Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Cham :
Springer International Publishing AG,
2022.
|
Edition: | 1st ed. |
Series: | SpringerBriefs in Economics Series
|
Subjects: | |
Online Access: | Click to View |
Table of Contents:
- Intro
- Preface
- Acknowledgments
- Contents
- *-1pc Value Creation and Managing Intellectual Property in the Life Science Industry
- Value Creation, Valuation and Business Models in the Pharmaceutical Sector
- 1 Value Principles in the Pharmaceutical Industry
- 2 Value Creation in the Pharmaceutical Industry
- 3 `Keeping Focus': The Traditional Value Token
- 4 `Extending Horizons': Innovation-Integration Across the Value Chain
- 5 Value Protection: Intellectual Property in the Life Sciences
- 5.1 Patent Evaluation
- 6 Modelling the Patent Value as a Stochastic Process
- 6.1 The Patent Life Model
- 6.2 Viewing a Generic Case
- 6.3 Interferon Beta 1a: A Real-World Case
- 7 The Future of Value and Valuation in Pharma
- References
- Limited Commercial Licensing Strategies: A Piecewise Deterministic Differential Game
- 1 Limited Commercial Licenses in the Pharmaceutical Industry
- 1.1 Probability of Issuing a CL
- 2 A Differential Game of Limited Commercial Licensing
- 2.1 Preliminaries
- 2.2 Profits and Sales in Each Regime
- 2.3 Switching Between Stages
- 2.4 The Problem
- 3 Solving the Model
- 4 Perspective
- References
- Partnership Models for R&
- D in the Pharmaceutical Industry
- 1 Introduction
- 2 The Problem of R&
- D Efficiency of Pharmaceutical Companies
- 2.1 Eroom's Law
- 2.2 Analysis of R&
- D Costs in the Pharmaceutical Sector
- 2.3 Analysis of Pipeline Drugs
- 3 New R&
- D Open Innovation Models for Pharmaceutical Companies
- 3.1 Mergers and Acquisitions
- 3.2 In-licensing Agreements
- 3.3 Outsourcing R&
- D Processes from CROs
- 3.4 R&
- D Collaborations
- 3.5 Public-Private Partnerships
- 3.6 Crowdsourcing
- 3.7 Innovation Centers
- 3.8 Open Source
- References
- *-1pc Modelling Specific Business Processes in the Life Science Industry.
- Pharma Tender Processes: Modeling Auction Outcomes
- 1 Introduction
- 2 Pharmaceutical Tendering
- 2.1 Pharmaceutical Tendering Mechanism in Different Countries
- 2.2 Effect of Pharmaceutical Tendering
- 3 Tendering as Auction: Scope and Concept
- 3.1 Tender Versus Auction
- 3.2 Independent Private Value Auction
- 3.3 First Price Sealed Auction
- 3.4 Number of Bidders
- 4 Empirical Methods for Price Auction Estimation
- 4.1 Bidding Price Determinants Estimation with Reduced Form Approach
- 4.2 Structural Estimation of Auction Models
- 4.3 Quantile-Based Non-parametric Estimation of Private Value
- 5 Non-parametric Estimation on Observational Data
- 5.1 Dataset
- 5.2 Visualization and Descriptive Analysis
- 5.3 Assumptions Validation
- 5.4 Modeling and Estimation
- 5.5 Adjustments and Lessons Learned
- References
- Multi-Echelon Inventory Optimization Using Deep Reinforcement Learning
- 1 Introduction
- 2 Challenges of Multi-Echelon Inventory Management from an Optimization Perspective
- 3 Literature Review of Inventory Management
- 4 Reinforcement Learning for Inventory Management
- 4.1 Markov (Decision) Processes
- 5 Introduction to Reinforcement Learning
- 5.1 Value-Based Methods
- 5.2 Policy-Based Methods
- 5.3 Actor-Critic Methods
- 6 Evaluation
- 7 Discussion of Results
- 8 Outlook
- 9 Conclusions
- 10 Acronyms
- References
- *-1pc Specialized Quantitative Tools in the Life Science Industry
- An Invitation to Stochastic Differential Equations in Healthcare
- 1 Introduction
- 1.1 Brownian Motions
- 1.2 Ito's Integral and Solutions of Geometric Brownian Motions (GBM)
- 1.3 Existence of Solutions of Stochastic Differential Equations
- 2 Numerical Methods for SDEs
- 2.1 Euler-Maruyama Method
- 2.2 -Maruyama Methods
- 2.3 Stochastic Runge-Kutta Methods
- 3 A Numerical Evidence on PK/PD Models.
- References
- Life Events that Cascade: An Excursion into DALY Computations
- 1 Introduction
- 2 The Hawkes-Cox Framework
- 2.1 The Choice of Kernel and the Rôle of δ
- 3 Dynkin's Formula
- 4 Theoretical Moments
- 4.1 The Moments of Counts in an Interval
- 4.2 The Covariance
- 5 Learning and Optimization
- 6 Synthetic Experiments
- 6.1 Calibration
- 7 Disability Adjusted Life Years
- 8 Concluding Remarks
- References.